Research Progress on the Anticancer Activities and Mechanisms of Polysaccharides From Ganoderma

Man Wang1, Fei Yu1

  • 1Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, China.

Insights

Ganoderma polysaccharides show significant anticancer properties, offering a natural approach to cancer therapy by regulating key biological processes. Further research into these compounds can improve cancer treatments.

Area of Science:

  • Oncology
  • Natural Products Chemistry
  • Immunology

Background:

  • Cancer is a leading global cause of death, with conventional therapies causing severe side effects.
  • Natural products, particularly Ganoderma polysaccharides, demonstrate promising anticancer activities.
  • Existing research highlights the potential of Ganoderma polysaccharides as natural chemopreventive agents.

Purpose of the Study:

  • To review recent findings on the role of Ganoderma polysaccharides in cancer pathogenesis.
  • To discuss the diverse mechanisms by which these compounds exert anticancer effects.
  • To propose future research directions for Ganoderma polysaccharides in cancer therapy.

Main Methods:

  • Literature review of studies on Ganoderma polysaccharides and cancer.
  • Analysis of mechanisms including DNA damage response, cell proliferation, apoptosis, immunity, and gut microbiota.
  • Synthesis of current understanding of clinical implications.

Main Results:

  • Ganoderma polysaccharides regulate critical cancer development pathways.
  • These compounds influence cancer cell proliferation, apoptosis, and immune response.
  • Evidence suggests modulation of gut microbiota and therapeutic sensitivity by Ganoderma polysaccharides.

Conclusions:

  • Ganoderma polysaccharides possess significant anticancer properties with multifaceted mechanisms.
  • Understanding these bioactive compounds can lead to improved cancer treatments.
  • Further research is crucial for developing novel therapeutic strategies for malignancies.